dihydroberberine has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, N; Li, C; Lu, Q; Mo, Z; Wu, B; Xie, J | 1 |
| Deng, AJ; Li, J; Li, ZH; Qin, HL; Song, HR; Wang, WJ; Wu, LQ; Zhang, HJ; Zhang, ZH | 1 |
2 other study(ies) available for dihydroberberine and Colitis Gravis
| Article | Year |
|---|---|
Dihydroberberine, an isoquinoline alkaloid, exhibits protective effect against dextran sulfate sodium-induced ulcerative colitis in mice.
Topics: Animals; Berberine; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Isoquinolines; Mice; Myeloid Differentiation Factor 88; NF-kappa B; Phytochemicals; Protective Agents; Signal Transduction; Toll-Like Receptor 4 | 2021 |
Versatile methods for synthesizing organic acid salts of quaternary berberine-type alkaloids as anti-ulcerative colitis agents.
Topics: Berberine; Colitis, Ulcerative; Hydrastis; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Regulatory Factor X Transcription Factors; Salts | 2016 |